You are viewing: UK Negative Pressure Wound Therapy Market analysis

The UK Negative Pressure Wound Therapy Market was valued at $100.78 Million in 2025 and projected to reach to $137.41 Million by 2030, representing a compound annual growth rate of 6.4%. The UK Negative Pressure Wound Therapy market is positioned for steady growth through 2030, supported by an aging population with increased chronic wound prevalence and NHS investment in advanced wound management protocols.

UK Negative Pressure Wound Therapy Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Negative Pressure Wound Therapy Market Trends and Insights

  • The UK market benefits from advanced healthcare infrastructure, increasing prevalence of chronic wounds, and strong adoption of advanced wound care technologies across NHS trusts and private healthcare providers.
  • The UK's aging population and rising incidence of diabetes-related complications are driving demand for NPWT solutions in hospitals, outpatient clinics, and home care settings. Growth in the UK market is supported by clinical evidence demonstrating NPWT efficacy in treating complex wounds, including diabetic ulcers, pressure injuries, and post-surgical wounds.
  • The UK healthcare system's emphasis on cost-effective treatment outcomes and reduced hospital readmissions has accelerated NPWT adoption.
  • Between 2025 and 2030, the UK market will likely see increased investment in portable and wearable NPWT devices, improved reimbursement pathways, and expanded access through integrated care systems..

Key Market Statistics

  • CAGR (2025-2030) 6.4% CAGR
  • Market Size, 2025 ~USD 100.78 Million
  • Forecast, 2030 ~USD 137.41 Million
  • Country UK

UK Negative Pressure Wound Therapy Market Overview

Market Valuation :

The UK Negative Pressure Wound Therapy market is valued at £100.78 million in 2025, with projected growth to £137.41 million by 2030, driven by increasing adoption across NHS trusts and private healthcare facilities.

Healthcare Infrastructure Advantage :

The UK's advanced healthcare infrastructure and established NHS procurement frameworks create a stable market environment for NPWT device manufacturers and service providers seeking to expand their presence.

Chronic Wound Prevalence :

Rising incidence of chronic wounds, diabetic ulcers, and post-surgical complications across the UK population is driving demand for advanced wound care solutions and NPWT adoption in clinical settings.

Technology Adoption Rate :

Strong uptake of advanced wound care technologies among UK healthcare providers reflects clinical confidence in NPWT efficacy and growing reimbursement support from NHS commissioning bodies.

UK Negative Pressure Wound Therapy Market Dynamics

  • Healthcare providers across England, Scotland, Wales, and Northern Ireland are increasingly integrating NPWT into standard care pathways for complex wounds, diabetic ulcers, and post-operative complications.
  • Regulatory support and clinical evidence continue to strengthen market confidence. Key growth drivers include expanding NHS procurement agreements, rising private healthcare demand, and technological innovations in portable and digital-enabled NPWT systems.
  • The market will benefit from increased awareness among clinicians and patients, coupled with improved reimbursement clarity.
  • Competition among device manufacturers is expected to drive product innovation and cost optimization, further accelerating adoption across UK healthcare settings..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The UK NPWT market is projected to grow from £100.78M (2025) to £137.41M (2030) at a 6.4% CAGR.
    • The UK's aging population and high diabetes prevalence are key drivers of NPWT demand across healthcare settings.
    • NHS adoption and reimbursement improvements are accelerating NPWT penetration in the UK market.
    • Portable and wearable NPWT technologies are expected to drive innovation and market expansion in the UK through 2030.

    Negative Pressure Wound Therapy Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment HOSPITALS (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 6.9% from 2025 to 2030
    Largest Segment CONVENTIONAL NPWT DEVICES (Product Type)
    Market Size Base Year (Billions) ~USD 2.75 (2025)
    Revenue Forecast (Billions) ~USD 3.84 (2030)
    Segments Covered Product Type, Wound Type, End User

    UK Negative Pressure Wound Therapy Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product Type

    • Conventional Npwt Devices
    • Npwt Accessories & Consumables
    • Single-Use Npwt Devices

    By Wound Type

    • Burns And Surgical & Open Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Traumatic Wounds
    • Venous Leg Ulcers

    By End User

    • Home Care Settings
    • Hospitals
    • Other End Users

    UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    HOME CARE SETTINGS52.3754.9357.6760.6263.7867.2370.9574.955.4
    HOSPITALS74.5479.6385.1991.2697.9105.27113.36122.237.5
    OTHER END USERS15.2315.7916.3917.0317.7318.519.3320.224.3
    TOTAL142.14150.34159.24168.91179.41191.01203.63217.46.4

    Target Audience

    • Medical Device Manufacturers : NPWT device manufacturers need UK-specific market data to develop localized go-to-market strategies, understand NHS procurement requirements, and identify partnership opportunities with UK healthcare providers.
    • Healthcare Providers & NHS Trusts : Hospital procurement teams and wound care specialists require market intelligence to justify NPWT investment decisions, benchmark adoption rates against peers, and optimize budget allocation for advanced wound care.
    • Private Healthcare Operators : Private hospital networks and independent healthcare providers need UK market insights to assess demand for premium NPWT services, identify patient segments, and develop competitive service offerings.
    • Investment & Consulting Firms : Private equity, venture capital, and management consultants need comprehensive UK market analysis to evaluate investment opportunities, assess portfolio company positioning, and guide strategic acquisitions in wound care.
    • Distributors & Healthcare Suppliers : Medical device distributors and healthcare supply companies require UK market forecasts and competitive analysis to optimize inventory planning, negotiate supplier agreements, and identify channel expansion opportunities.

    Key Companies in the UK Negative Pressure Wound Therapy Market

    CompanyHQOwnershipStrongest segments
    NITTO DENKO CORPORATIONJapanPublic CompanyConventional NPWT (materials content),Single-use NPWT (materials content),NPWT Consumables (dressings, drapes, tapes),
    COLOPLAST A/SDenmarkPublic CompanyConventional NPWT systems,Single-use NPWT,Consumables,
    SOLVENTUMUnited StatesPublic CompanyConventional NPWT Systems,Single-use NPWT,Consumables (Dressings, Canisters, Interfaces),
    SMITH+NEPHEWUnited KingdomPublic CompanyConventional NPWT Systems,Single-use NPWT Systems,Consumables (Dressings & Canisters),
    CARDINAL HEALTHUnited StatesPublic CompanyConventional NPWT Systems,Single-use NPWT,Consumables,
    MöLNLYCKE ABSwedenPrivate CompanyConventional NPWT,Single-use NPWT,Consumables,
    CONVATEC GROUP PLCUnited KingdomPublic CompanyConventional NPWT Systems,Single-use NPWT,Consumables (Dressings, Canisters, Tubing),
    PAUL HARTMANN AGGermanyPublic CompanyConventional NPWT systems,Single-use NPWT,NPWT Consumables (dressings, canisters, tubing),
    AVERY DENNISON CORPORATIONUnited StatesPublic CompanyConventional NPWT (materials inputs),Single-use NPWT (materials inputs),Consumables (dressings, drapes, interface materials),
    BENQ MATERIALS CORPORATIONTaiwanPublic CompanyConventional NPWT systems,Single-use NPWT,NPWT consumables (dressings, drapes, canisters),
    DOUBLE MEDICAL TECHNOLOGY INC.ChinaPublic CompanyConventional NPWT Systems,Single-use NPWT,Consumables (Dressings & Canisters),

    NITTO DENKO CORPORATION

    Nitto Denko Corporation is a Japanese public company founded in 1918 with 26,477 employees. The company operates as a diversified manufacturer with operations across multiple industrial sectors.

    COLOPLAST A/S

    Coloplast A/S is a Danish public company established in 1954 with 17,083 employees. The company specializes in medical devices and healthcare solutions.

    SOLVENTUM

    Solventum is a United States public company established in 2023 with 20,584 employees. The company operates in the healthcare and industrial sectors.

    SMITH+NEPHEW

    Smith+Nephew is a United Kingdom-based public company founded in 1856 with 16,988 employees. The company is a global medical technology provider specializing in orthopedics, wound care, and surgical products.

    CARDINAL HEALTH

    Cardinal Health is a United States public company founded in 1979 with 55,392 employees. The company is a major healthcare services and products distributor serving hospitals, pharmacies, and other healthcare providers.

    MöLNLYCKE AB

    Mölnlycke AB is a Swedish private company established in 1849 with 8,463 employees. The company specializes in healthcare and hygiene products.

    CONVATEC GROUP PLC

    ConvaTec Group PLC is a United Kingdom-based public company founded in 1978 with 10,910 employees. The company develops and manufactures medical devices and products for ostomy care, continence care, and wound care.

    PAUL HARTMANN AG

    Paul Hartmann AG is a German public company founded in 1818 with 10,066 employees. The company produces medical and hygiene products for healthcare and consumer markets.

    AVERY DENNISON CORPORATION

    Avery Dennison Corporation is a United States public company founded in 1935 with 35,000 employees. The company manufactures pressure-sensitive materials, labels, and packaging solutions for various industries.

    BENQ MATERIALS CORPORATION

    BenQ Materials Corporation is a Taiwan-based public company founded in 1998 with 1,317 employees. The company manufactures specialty materials and components.

    DOUBLE MEDICAL TECHNOLOGY INC.

    Double Medical Technology Inc. is a China-based public company founded in 2004 with 4,704 employees. The company manufactures medical devices and healthcare products.

    Reasons to Buy this Report

    • UK-Specific Market Sizing : Access precise valuation data for the UK market (£100.78M in 2025) with detailed forecasts through 2030, enabling accurate business planning and investment decisions tailored to the British healthcare landscape.
    • NHS Procurement Insights : Understand NHS commissioning trends, procurement frameworks, and adoption patterns across England, Scotland, Wales, and Northern Ireland to identify opportunities within public healthcare systems.
    • Competitive Landscape Analysis : Gain intelligence on UK-based and international competitors operating in the NPWT market, including their market positioning, product portfolios, and strategic initiatives within British healthcare.
    • Regulatory & Reimbursement Environment : Detailed analysis of UK regulatory pathways, NICE guidance, and NHS reimbursement policies that directly impact market access, pricing strategies, and commercial viability for NPWT solutions.
    • Growth Opportunity Identification : Identify high-potential segments within the UK market, including geographic hotspots, clinical specialties with unmet needs, and emerging applications to prioritize market entry and expansion strategies.

    Frequently asked questions

    What is the current size of the UK Negative Pressure Wound Therapy market?

    The UK NPWT market is valued at £100.78 million in 2025 and is expected to reach £137.41 million by 2030.

    What is the growth rate of the UK NPWT market?

    The UK NPWT market is growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2030.

    What factors are driving growth in the UK NPWT market?

    Key drivers include the UK's aging population, rising diabetes prevalence, NHS adoption of advanced wound care, improved reimbursement pathways, and clinical evidence supporting NPWT efficacy.

    Which healthcare settings in the UK are adopting NPWT technology?

    NPWT adoption in the UK spans NHS hospitals, outpatient clinics, private healthcare providers, and home care settings, with increasing integration across integrated care systems.

    What innovations are expected in the UK NPWT market by 2030?

    The UK market is expected to see growth in portable and wearable NPWT devices, improved digital connectivity, enhanced patient monitoring capabilities, and expanded access through community care networks.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the negative pressure wound therapy market. Exhaustive secondary research was done to collect information on the negative pressure wound therapy industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the negative pressure wound therapy market.

    The four steps involved in estimating the market size are:

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global negative pressure wound therapy market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the negative pressure wound therapy market. The primary sources from the demand side include pharmaceutical companies, biotechnology companies, CROs, pharmacies, medical device companies, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

    The following is a breakdown of the primary respondents:

    Negative Pressure Wound Therapy Market

    Note 1: Other designations include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global negative pressure wound therapy market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. The global negative pressure wound therapy market was split into various segments and sub-segments based on:

    • List of major players operating in the products market at the regional and/or country level
    • Product mapping of negative pressure wound therapy providers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from negative pressure wound therapy (or the nearest reported business unit/product category)
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global negative pressure wound therapy market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    The research methodology used to estimate the market size includes the following:

    Negative Pressure Wound Therapy Market

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Negative pressure wound therapy is a treatment that pulls fluid and bacteria out of a wound to help it heal better. Some healthcare providers call it vacuum-assisted therapy. It works by creating suction. A provider can use this treatment to heal soft tissue on many different parts of your body.

    Stakeholders

    • NPWT Device Manufacturers
    • Hospitals and ASCs
    • Research and Consulting Firms
    • Distributors of NPWT Devices
    • Contract Manufacturers of NPWT Devices
    • Venture Capitalists and Investors
    • Government Wound Care Organizations

    Report Objectives

    • To define, describe, segment, and forecast the global negative pressure wound therapy market by product type, wound type, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall negative pressure wound therapy market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
    • To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region

     

    Get the Full Negative Pressure Wound Therapy Market Report

    Full forecast, segment splits, and company analysis for all Negative Pressure Wound Therapy Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status